Stock GRNA GREENLIGHT BIOSCIENCES HOLDINGS PBC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Greenlight Biosciences Holdings Pbc

Equities

GRNA

US39536G1058

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Greenlight Biosciences Holdings Pbc

GreenLight Biosciences Completes Going Private Transaction MT
Canaccord Genuity Downgrades GreenLight Biosciences to Hold From Buy, Adjusts Price Target to $0.30 From $4 MT
GreenLight Biosciences Agrees to be Acquired by Fall Line Capital-Led Group in $45.5 Million Deal MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q1 Revenue $3.8M MT
GreenLight Biosciences Gets Interest Indication From Fall Line Endurance Fund; Shares Rise After-Hours MT
Greenlight Biosciences Q4 EPS Loss Narrow, Revenue Rises MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q4 Revenue $3M MT
GreenLight Biosciences Secures Rwanda FDA Approval for COVID-19 Clinical Trial MT
GreenLight Biosciences, Epivax Therapeutics to Jointly Develop Personalized Cancer Vaccines MT
Canaccord Initiates GreenLight Biosciences With Buy Rating, Price Target is $4 MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Posts Q3 Revenue $1.7M MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Posts Q3 Loss $-0.27 MT
Credit Suisse Initiates GreenLight Biosciences Holdings, Origin Materials with Outperform Ratings, Says Both Represent Next-Generation Chemical Technologies MT
ETF Preview: ETFs, Futures Slightly Higher Premarket After September Producer Price Index Report MT
GreenLight Biosciences to Cut Jobs, Costs as Part of Planned Realignment MT
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday MT
Insider Buy: Greenlight Biosciences Holdings, Pbc MT
GreenLight Biosciences Reports Aggregate Insider Share Purchases of More Than 9 Million -- Stock Jumps in Pre-Market MT
Insider Buy: Greenlight Biosciences Holdings, Pbc MT
GreenLight Biosciences Q2 Net Loss Widens, Revenue Climbs MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Posts Q2 Revenue $1.77M MT
GreenLight Biosciences Enters $109 Million Private Placement MT
Top Premarket Gainers MT
GreenLight Biosciences, Samsung Biologics Complete Engineering Run for mRNA Partnership MT
GreenLight Biosciences, Serum Institute of India Enter Licensing Deal to Develop Messenger RNA Products MT

Chart Greenlight Biosciences Holdings Pbc

Chart Greenlight Biosciences Holdings Pbc
More charts

Company Profile

Environmental Impact Acquisition Corp is a blank check company. The Company's business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus on sectors, including smart building technologies, smart grid and smart city, energy efficiency & decarbonization, renewable energy & distributed generation, electric vehicles & mobility, agriculture & food technology, recycling & remediation, and water & bioresources. It is neither engaged in any operations nor generated any revenues.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. GRNA Stock
  4. News Greenlight Biosciences Holdings Pbc
  5. Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q1 Revenue $3.8M